Breaking News

Lilly Strengthens Parenteral Manufacturing Operations

Will invest more than $470 million to build new manufacturing facility in North Carolina

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Eli Lilly and Company has unveiled plans to invest over $470 million and create more than 460 new jobs in Durham, NC. The project will bring a new state-of-the-art pharmaceutical manufacturing facility to North Carolina’s Research Triangle Park.   This new manufacturing site will be a state-of-the-art facility that produces parenteral (or injectable) products and delivery devices. To operate the site, Lilly will create more than 400 jobs in highly skilled positions such as scientists, engi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters